Xeruborbactam

DB21512InvestigationalSmall molecule

Xeruborbactam is a small molecule drug. The usage of the INN stem '-bactam' in the name indicates that Xeruborbactam is a ẞ-lactamase inhibitor. Xeruborbactam is under investigation in clinical trial... Xeruborbactam is under investigation in clinical trial NCT07104162 (A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment).

Chemical structure of Xeruborbactam
Formula / weight
C10H8BFO4 · 221.98 g/mol (avg)
Code names
QPX7728 · QPX7831

Resolves to

Compound
UNIIDE79L822UYCAS2170834-63-4ChEMBLCHEMBL4633785ChEBI758109PubChem140830474
Structure
InChIKeyKOHUFVUIYUCFNG-PHDIDXHHSA-NSMILESOB1OC2=C(C(O)=O)C(F)=CC=C2[C@H]2C[C@@H]12
Targets
P00807blaZ

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Xeruborbactam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In